Cargando…
Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection
In this report we test the hypothesis that long-term virus-induced alterations in CYP occur from changes initiated by the virus that may not be related to the immune response. Enzyme activity, protein expression and mRNA of CYP3A2, a correlate of human CYP3A4, and CYP2C11, responsive to inflammatory...
Autores principales: | Callahan, Shellie M, Wonganan, Piyanuch, Croyle, Maria A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565663/ https://www.ncbi.nlm.nih.gov/pubmed/18826641 http://dx.doi.org/10.1186/1743-422X-5-111 |
Ejemplares similares
-
PEGylated Adenoviruses: From Mice to Monkeys
por: Wonganan, Piyanuch, et al.
Publicado: (2010) -
Drug-Virus Interaction: Effect of Administration of Recombinant Adenoviruses on the Pharmacokinetics of Docetaxel in a Rat Model
por: Wonganan, Piyanuch, et al.
Publicado: (2008) -
Effective Genetic Expression of Nanoantibodies by Recombinant
Adenoviral Vector in vitro
por: Gribova, I.Yu., et al.
Publicado: (2011) -
Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001) -
Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)